Extended 10-Panel
Broad 10-substance screening covering CDT, cocaine, ketamine, amphetamines, 3-MMC, LSD, GHB, phenibut, heroin marker, and opiates.
A 2C-B urine test is a qualitative screening that detects the presence of 2C-B (4-bromo-2,5-dimethoxyphenethylamine) or its metabolites in urine. 2C-B is a synthetic psychedelic phenethylamine with stimulant and hallucinogenic properties.
Doctor's Assessment Included
This test detects the presence of 2C-B and its metabolites in urine. 2C-B is a synthetic phenethylamine compound that is not detected by standard drug screening panels. The test provides a qualitative result indicating whether 2C-B metabolites are present above the assay cut-off level.
Because 2C-B is structurally distinct from other commonly screened substances, a targeted assay is required for reliable detection.
Detection of 2C-B may be relevant for clinical assessment, forensic investigations, and extended drug screening programmes. The substance is not included in standard workplace drug panels, making targeted testing important when its use is suspected.
Accurate identification supports appropriate clinical decision-making and helps distinguish 2C-B from other phenethylamine derivatives.
Testing may be relevant when 2C-B use is suspected, as part of extended drug screening panels, or during forensic evaluations. Standard immunoassay panels do not detect 2C-B.
Consult a healthcare professional for guidance on when testing is appropriate and how to interpret results.
These panels measure values from the same category as this marker.
Broad 10-substance screening covering CDT, cocaine, ketamine, amphetamines, 3-MMC, LSD, GHB, phenibut, heroin marker, and opiates.
Screen for 5 commonly requested substances including CDT, cocaine, ketamine, amphetamines, and 3-MMC.
CDT biomarker test designed to indicate chronic alcohol consumption patterns.
Individual cocaine metabolite screening with laboratory confirmation.
2C-B
€146,-